EQUASENS ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 32% by 2022.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
● The tendency within the weekly time frame is positive above the technical support level at 63 EUR
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at EUR 83.7.
● The stock is close to a major daily resistance at EUR 84.4, which should be gotten rid of so as to gain new appreciation potential.
● The company's earnings releases usually do not meet expectations.
● Based on current prices, the company has particularly high valuation levels.
● The firm trades with high earnings multiples: 38.68 times its 2020 earnings per share.
● The company is not the most generous with respect to shareholders' compensation.
